[HTML][HTML] RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene …
JH Mendler, K Maharry, MD Radmacher… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Journal of clinical oncology, 2012•ncbi.nlm.nih.gov
RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With
Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA
Expression Signatures - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC3732007 Other Formats PubReader PDF (240K) Actions Cite Collections Share …
Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA
Expression Signatures - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC3732007 Other Formats PubReader PDF (240K) Actions Cite Collections Share …
Abstract
Purpose
To determine the association of RUNX1 mutations with therapeutic outcome in younger and older patients with primary cytogenetically normal acute myeloid leukemia (CN-AML) and with gene/microRNA expression signatures.
ncbi.nlm.nih.gov